Jack V. Greiner

ORCID: 0000-0003-1659-1020
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ocular Surface and Contact Lens
  • Glaucoma and retinal disorders
  • Corneal Surgery and Treatments
  • Connexins and lens biology
  • Corneal surgery and disorders
  • Allergic Rhinitis and Sensitization
  • Advancements in Transdermal Drug Delivery
  • Spectroscopy Techniques in Biomedical and Chemical Research
  • Dermatology and Skin Diseases
  • Retinal Development and Disorders
  • Lipid Membrane Structure and Behavior
  • Contact Dermatitis and Allergies
  • Intraocular Surgery and Lenses
  • Retinal Diseases and Treatments
  • Biochemical effects in animals
  • Facial Rejuvenation and Surgery Techniques
  • Urticaria and Related Conditions
  • COVID-19 and healthcare impacts
  • Ocular Infections and Treatments
  • Advanced MRI Techniques and Applications
  • Mast cells and histamine
  • Dermatologic Treatments and Research
  • Infection Control and Ventilation
  • Drug-Induced Adverse Reactions
  • Nasolacrimal Duct Obstruction Treatments

Smith-Kettlewell Eye Research Institute
2014-2025

Massachusetts Eye and Ear Infirmary
2015-2025

Harvard University
2012-2025

Massachusetts Eye Research and Surgery Institute
1988-2025

Tufts University
2017-2024

Andover Eye Associates
2023

Midwestern University
2000-2022

Ocular Surface Center
2003-2022

Johns Hopkins University
2021

Johns Hopkins Medicine
2021

To evaluate the safety and effectiveness of LipiFlow System compared to iHeat Warm Compress (WC) for adults with meibomian gland dysfunction (MGD).This was a non-significant risk, prospective, open-label, randomized, crossover multicenter clinical trial. One hundred thirty-nine subjects were randomized between (n=69) WC control (n=70). Subjects in group received 12-minute treatment reexamined at 1 day, 2 weeks 4 weeks. Control 5-minute instructions perform same daily At weeks, they crossed...

10.1097/ico.0b013e318239aaea article EN Cornea 2012-01-06

Objectives. The lid wiper is defined as that portion of the marginal conjunctiva upper eyelid wipes ocular surface during blinking. purpose this study was to investigate whether epitheliopathy occurred with patients who reported dry eye symptoms, yet had normal fluorescein breakup time (FBUT) and Schirmer test values an absence corneal staining. Methods. One hundred were divided into two groups based on presence or determined Standard Patient Evaluation Eye Dryness questionnaire. Other...

10.1097/01.icl.0000140910.03095.fa article EN Eye & Contact Lens Science & Clinical Practice 2005-01-01

Alterations in the tear film lipid layer as a function of blinking were investigated using custom-designed specular reflection monitoring system. The 104 subjects under conditions normal ("baseline") and "forceful" was quantitated on basis specific interference colors. Deliberate, forceful found to significantly increase thickness (LLT) film. magnitude be correlated with baseline LLT values; individuals values 75-150 nm demonstrated mean 33 following blinking, whereas < or = 60 experienced...

10.1097/00003226-199407000-00012 article EN Cornea 1994-07-01

To evaluate whether dry-eye symptoms are associated with epitheliopathy of that portion the upper eyelid marginal conjunctiva-the lid wiper-that wipes ocular, or contact lens surface, during blinking.Subjects were divided into two groups based on presence absence symptoms. The wiper asymptomatic (n=75) and symptomatic (n=30) soft wearers was examined, following instillation fluorescein rose bengal dyes. Lid-wiper staining graded zero to 3.Eighty percent subjects displayed lid-wiper compared...

10.1097/01.icl.0000029344.37847.5a article EN PubMed 2002-10-01

Purpose. Warm-compress therapy applied to the skin of closed eyelids has been recommended as a treatment for meibomian gland dysfunction (MGD). Previous studies have evaluated effects warm-compress on tear-film fluorescein break-up time and tear evaporation rate. The purpose this study was determine if lipid layer thickness (TFLLT) altered following 5, 15, 30 minutes warm, moist compress therapy. Methods. Twenty patients with diagnosis dry eye associated MGD baseline TFLLT ≤ 90 nm (baseline...

10.1097/01.icl.0000060998.20142.8d article EN Eye & Contact Lens Science & Clinical Practice 2003-04-01

(1) To investigate the relationship between dry eye symptoms and lipid layer thickness (LLT) in patients presenting for routine examination (2) to consider practicality of interferometry a clinical practice.Patients consecutively examinations were recruited (n = 137, age range 18-60 years, mean 41.7 +/- 15.5 102 females 35 males). Patients required complete Standard Patient Evaluation Eye Dryness (SPEED) questionnaire after which their LLT was evaluated using new interferometer (Ocular...

10.1097/ico.0b013e318191b870 article EN Cornea 2009-07-20

10.1016/s0002-9394(14)76821-7 article EN American Journal of Ophthalmology 1978-08-01

Purpose: To evaluate the effect of a single treatment with LipiFlow® Thermal Pulsation System on signs meibomian gland dysfunction (MGD) and dry eye symptoms over 9-month period.Methods: Patients (n = 42 eyes, 21 subjects) diagnosed MGD were recruited for non-significant risk, prospective, open-label, 1-month clinical trial. received 12-minute using each eye. The device applies heat to conjunctival surfaces upper lower inner eyelids while simultaneously applying pulsatile pressure outer...

10.3109/02713683.2011.631721 article EN Current Eye Research 2012-02-10

Crystalline lens and striated muscle exist at opposite ends of the metabolic spectrum. Lens is a metabolically quiescent tissue, whereas mechanically dynamic tissue with high-energy requirements, yet both tissues contain millimolar levels ATP (&gt;2.3 mM), far exceeding their underlying needs. We explored intracellular concentrations across multiple cells, tissues, species, domains to provide context for interpreting lens/striated data. Our database revealed that high are ubiquitous diverse...

10.3390/biology10111166 article EN cc-by Biology 2021-11-12

The objective of this study was to evaluate the safety and intraocular pressure (IOP)-lowering effects over 24 months biodegradable bimatoprost sustained-release implant (Bimatoprost SR) administration versus topical 0.03% in patients with open-angle glaucoma (OAG).This a phase I/II, prospective, 24-month, dose-ranging, paired-eye controlled clinical trial. At baseline following washout, adult OAG (N = 75) received Bimatoprost SR (6, 10, 15, or 20 µg) intracamerally eye; fellow eye once...

10.1007/s40265-019-01248-0 article EN cc-by-nc Drugs 2019-12-28

Purpose. Because the lipid layer of tear film is recognized as a critical component in dry eye disease, this study was designed to determine if single drop either Soothe or Systane produces significant increase thickness (LLT) for subjects reporting symptoms indicative eyes. Methods. A double-blind, internally paired performed. custom-built interferometer, enabling characterization interference patterns, used quantify baseline LLT (OU) eligible subjects. Inclusion criteria included: 1)...

10.1097/01.opx.0000171818.01353.8c article EN Optometry and Vision Science 2005-07-01

To (1) determine an optimal method of warm compress (WC) application to maximize heating meibomian glands in minimal time, (2) the maximum inner eyelid temperature achievable during 30 min routine WC application, (3) examine cooling curve for 10 after WCs have been discontinued.Subjects were randomly assigned one three methodologies. Group A (GrA), (n = 10): 15 without reheating. GrB, with reheating every 2 min. GrC, 12): optimizing contact lower lid and heated 45 +/- 0.5 degrees C. Outer...

10.1097/opx.0b013e318181adef article EN Optometry and Vision Science 2008-07-28

The purpose of this study was to investigate the prevalence lid wiper epitheliopathy (LWE) in patients diagnosed with dry eye disease (DED).Patients were recruited for two groups. Inclusion criteria DED group (n = 50) was: a score greater than 10 Standard Patient Evaluation Eye Dryness questionnaire, fluorescein break-up time 5 seconds or less, corneal and conjunctival staining fluorescein, lissamine green Grade 1 (scale 0-3), Schirmer test anesthesia mm less. For asymptomatic 50), inclusion...

10.1097/ico.0b013e3181ba0cb2 article EN Cornea 2010-03-18

The inner border of the eyelid margin is critically important for ocular surface integrity because it guarantees thin spread tear film. Its exact morphology in human still insufficiently known. histology serial sections upper and lower lid margins whole-mount specimens from 10 body donors was compared to vivo confocal microscopy eight eyes with a Heidelberg retina-tomograph (HRT II) attached Rostock cornea module. Behind posterior Meibomian orifices, cornified epidermis stopped abruptly...

10.1111/j.1469-7580.2011.01355.x article EN Journal of Anatomy 2011-03-18

To determine the 1-year post-treatment dry eye status of subjects with meibomian gland dysfunction and symptoms after receiving a single LipiFlow Thermal Pulsation System treatment.Single-centre, prospective, observational, open-label, 1-month-registered clinical trial follow-up examination.Patients evaporative disease who had participated in registered 1-month trial.Eighteen 30 initially enrolled were able to return for follow-up. Both eyes all patients treated 12-min treatment using...

10.1111/ceo.12033 article EN Clinical and Experimental Ophthalmology 2012-11-13

Purpose: The present study examined the long-term (3 years) effects of a single (12 min) thermal pulsation system (TPS) treatment on symptomatic patients with evaporative dry eye disease (DED) secondary to meibomian gland dysfunction (MGD). Methods: In this prospective, cohort, observational, single-center design, signs (meibomian secretion [MGS] scores and tear film breakup time [TBUT]) symptoms (Ocular Surface Disease Index [OSDI] Standard Patient Evaluation Eye Dryness [SPEED]...

10.1097/icl.0000000000000166 article EN Eye & Contact Lens Science & Clinical Practice 2015-07-29
Jason Bacharach Andrew J. Tatham Gloria E. Ferguson Sandra Belalcázar Hagen Thieme and 95 more Margot L. Goodkin Michelle Y. Chen Qiang Guo Jeen Liu Michael R. Robinson Marina Bejanian David Wirta Arturo Alezzandrini Gabriel Bercovich Pablo Deromedis Federico Furno Sola Carolina Gentile S. Lerner Anahi Lupinacci Carlos Zeolite Catherine M. Birt Andrew Crichton Sébastien Gagné Michael Giunta Paul Harasymowycz Delan Jinapriya Marcelo T. Nicolela Donald R. Nixon Patrick Saurel David Yan Darana Yuen Santiago Arango Sandra Belalcázar Alexander Martínez Juan Camilo Restrepo Vladimír Korda Jana Kadlecová Jitka Svačinová Hany A. Khairy Hani El Ibiary Zeinab El Sanabary Katharina Bell Roman Greslechner Joerg Michael Koch K Lorenz Isabel Oberacher-Velten Stefanie Schmickler C Schuart Hagen Thieme Francesco Bandello Carlo Cagini Michele Figus Leonardo Mastropasqua Luca Rossetti Maurizio G. Uva Sandragasu Thayanithi Anthony P. Wells Rahat Husain Victor Koh Dawn Lim Tin Aung Petrus Gous Lynette Venter Changwon Kee Michael S. Kook Ki Ho Park Muhsin Eraslan Özcan Kayıkçıoğlu Nilgün Yıldırım Rupert Bourne Anshoo Choudhary M. Francesca Cordeiro Vincent Dubois James Kirwan Sheng Yang Lim Keith R. Martin Antony Nithy Avinash Prabhu Andrew J. Tatham Ahmad Amir Jason Bacharach Howard Barnebey Allen D. Beck Lance Bergstrom Navaneet S.C. Borisuth James D. Branch Jonathan Briggs Stephen Bylsma Peter Chang William C. Christie Frank Cotter Michael Depenbusch Damien F. Goldberg Jack V. Greiner Shailesh Gupta Ron Gutmark Ying Han Sebastian Heersink Malik Y. Kahook Albert S Khouri

To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of 10 15 µg bimatoprost implant in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). This randomized, 20-month, multicenter, masked, parallel-group, phase 3 trial enrolled 528 OAG OHT an open iridocorneal angle inferiorly study eye. Study eyes were administered on day 1, week 16, 32, twice-daily topical timolol maleate 0.5%. Primary endpoints IOP change from baseline through 12. Safety measures...

10.1007/s40265-021-01624-9 article EN cc-by-nc Drugs 2021-11-01
Coming Soon ...